Since versican-V1 is prominently elevated in MS lesions with low BCAS1+ premyelinating oligodendrocytes, we plated murine (Fig. 2a) and human (Fig. 2f) OPCs onto versican-V1 in culture. This evidence concerns the gene BCAS1 and myeloid sarcoma.